- 作者：Krista Kinard ; MDAuthor Vitae ; Allison Jarstad ; BS ; Randall J. Olson ; MD ; randallj.olson@hsc.utah.edu
- 刊名：Journal of Cataract and Refractive Surgery
- 出版年：2013
- 出版时间：April, 2013
- 年：2013
- 卷：39
- 期：4
- 页码：590-597
- 全文大小：381 K
Purpose
To select a normal post-cataract-surgery cohort, determine visual quality parameters, and compare these parameters with self-reported satisfaction and visual function.Setting
John A. Moran Eye Center, University of Utah, Salt Lake City, Utah, USA.
Design
Retrospective cohort study.
Methods
A cohort of pseudophakic patients was selected based on uneventful surgery, good corrected visual acuity (no worse than logMAR 0.02), and lack of ocular complaints or pathology including dry-eye syndrome or posterior capsule opacification. A single-piece high-refractive-index acrylic intraocular lens, age 50 or older, and at least 1 year out from surgery were other inclusion criteria. Testing included logMAR corrected distance visual acuity (CDVA), mesopic 10 % contrast logMAR CDVA with and without glare, straylight determination, Rasch-modified National Eye Institute Visual Function questionnaire 11R (NEI VF-11R), custom pseudophakic dysphotopsia survey, and overall satisfaction question. Correlations were determined between these parameters.
Results
Of the 2953 patients considered, 70 patients met?all criteria, provided consent, and enrolled. Only pseudophakic dysphotopsia (r = ?0.60; P<.0001) and the NEI VF-11R (r?=??0.44; P<.0001) correlated with overall satisfaction. In addition, pseudophakic dysphotopsia correlated with the NEI VF-11R (r = 0.58; P<.0001).
Conclusions
When evaluating a highly controlled population with expected high satisfaction after cataract surgery, pseudophakic dysphotopsia was clearly the only significant dissatisfier. Furthermore, dysphotopsia highly correlated with the NEI VF-11R questionnaire; thus, symptoms of dysphotopsia are also seen to have functional significance. A shortened NEI VFQ survey and satisfaction correlated strongly with the full survey.
Financial Disclosure
Dr. Olson has been a consultant to Abbott Medical Optics, Inc., Becton, Dickinson and Co., and Allergan, Inc. He has received grant support from Abbott Medical Optics, Inc., and Allergan, Inc. No author has a financial or proprietary interest in any material or method mentioned.